tacrine and purine

tacrine has been researched along with purine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Bai, Y; Feng, X; Gao, Z; Hong, X; Huang, H; Jin, J; Lin, M; Liu, X; Ma, F; Qu, C; Sui, H; Sun, B; Sun, J; Zhang, H; Zhang, Z; Zhao, Y; Zhou, Q; Zhu, A; Zhu, Y; Zou, C	1

Other Studies

1 other study(ies) available for tacrine and purine

Article	Year
Targeting CLK3 inhibits the progression of cholangiocarcinoma by reprogramming nucleotide metabolism. The Journal of experimental medicine, 2020, 08-03, Volume: 217, Issue:8 Topics: Amino Acid Substitution; Bile Duct Neoplasms; Cell Line, Tumor; Cellular Reprogramming; Cholangiocarcinoma; Drug Delivery Systems; Gain of Function Mutation; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; Mutation, Missense; Neoplasm Proteins; Phosphorylation; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Purines; Tacrine; Up-Regulation	2020

Article

Year

Targeting CLK3 inhibits the progression of cholangiocarcinoma by reprogramming nucleotide metabolism.

The Journal of experimental medicine, 2020, 08-03, Volume: 217, Issue:8

Topics: Amino Acid Substitution; Bile Duct Neoplasms; Cell Line, Tumor; Cellular Reprogramming; Cholangiocarcinoma; Drug Delivery Systems; Gain of Function Mutation; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; Mutation, Missense; Neoplasm Proteins; Phosphorylation; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Purines; Tacrine; Up-Regulation

2020